Across TCGA pan-cancer cohorts, MIR30A RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR30A data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR30A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR30A expression acts as an unfavorable survival marker.
BLCA, KIRP, and ESCA are the cancer types where MIR30A RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.